Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuation Study suggests weight regain may be less common than…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse…
US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
Kenvue urges US FDA to reject request for Tylenol’s autism warning
Oct 20 (Reuters) – Kenvue (KVUE.N), opens new tab has urged U.S. regulators to reject a request seeking…